Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enoxaparin in advanced NSCLC
NCT00771563Phase 3Completed
- Start
- Jun 2008
- Primary completion
- Oct 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of enoxaparin in non-small cell lung cancer (NSCLC). Started Jun 2008; status: completed.
02
Drugs
enoxaparin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00771563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00771563.